A new deep-learning AI algorithm significantly lowered false positives in lung nodule malignancy assessment while maintaining high detection rates.
Key Details
- 1Deep-learning algorithm estimated lung nodule malignancy risk using LDCT data.
- 2Trained on 16,077 nodules (1,249 malignant) from the NLST; validated on a pooled cohort of 4,146 participants and 7,794 nodules.
- 3AUC for AI model was equal or superior to PanCan: ~0.98 (1yr), 0.96 (2yr) in pooled cohort; up to 0.95 for indeterminate nodules.
- 4For size-matched nodules, AI model AUC was 0.79 vs. PanCan at 0.6.
- 5At 100% sensitivity for cancer, AI flagged 68.1% of benign nodules as low-risk vs. PanCan's 47.4% (39.4% relative reduction in false positives).
- 6Authors stress the need for prospective clinical validation before routine use.
Why It Matters
Reducing false positives in lung cancer screening can minimize unnecessary procedures, patient anxiety, and healthcare costs. Improved AI-based risk stratification stands to improve the efficiency and effectiveness of LDCT lung cancer screening programs.
Source
AuntMinnie
Related News
•Radiology Business
Real-World Study: Radiology AI Best in Emergency and Inpatient Settings
A commercial AI tool for intracranial aneurysm detection outperformed in inpatient and emergency settings but yielded limited benefits for outpatients in a major health system study.
•Radiology Business
New Rubric Enhances Safety of AI-Generated Radiology Summaries
Researchers developed a five-factor rubric to assess the safety and quality of AI-generated, patient-friendly radiology report summaries.
•Radiology Business
Healthcare Leader Warns AI Will Dominate Diagnostic Radiology
A leading oncologist urges future radiologists to specialize in interventional procedures due to AI advances in image interpretation.